ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Piperidine → Ether hydrochloride

HRID 849406
印刷

反応式

HRID 849406 の反応式
[C:1]([N:8]1[CH:12]=[CH:11]N=[CH:9]1)(N1[CH:7]=[CH:6]N=C1)=[O:2].[ClH:13].Cl.[NH:15]1[CH:19]=[C:18]([CH2:20][N:21]2[C:27]3[CH:28]=[C:29]([NH2:32])[CH:30]=[CH:31][C:26]=3[CH2:25][N:24]([C:33]([C:35]3[C:44]4[C:39](=[CH:40][CH:41]=[CH:42][CH:43]=4)[CH:38]=[CH:37][CH:36]=3)=[O:34])[CH2:23][CH2:22]2)[N:17]=[CH:16]1.[CH2:45](N(CC)CC)[CH3:46].N1CCCCC1>C(Cl)Cl.C([O-])(O)=O.[Na+].C(Cl)(Cl)Cl>[ClH:13].[ClH:13].[NH:15]1[CH:19]=[C:18]([CH2:20][N:21]2[C:27]3[CH:28]=[C:29]([NH:32][C:1]([N:8]4[CH2:9][CH2:46][CH2:45][CH2:11][CH2:12]4)=[O:2])[CH:30]=[CH:31][C:26]=3[CH2:25][N:24]([C:33]([C:35]3[C:44]4[C:39](=[CH:40][CH:41]=[CH:42][CH:43]=4)[CH:38]=[CH:37][CH:36]=3)=[O:34])[CH2:23][CH2:22]2)[N:17]=[CH:16]1.[ClH:13].[CH3:6][CH2:7][O:34][CH2:33][CH3:35]
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 4

HCID 8082PiperidineHCID 8471TriethylamineHCID 682631,1'-CarbonyldiimidazoleHCID 1784786502,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-4-(1-naphthalenylcarbonyl)-8-amino-1H-1,4-benzodiazepine, dihydrochloride

生成物 2

HCID 10953452Ether hydrochloride
HCID 178478887
N-[2,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-4-(1-naphthalenylcarbonyl)-1H-1,4-benzodiazepin-8-yl]-1-piperidinecarboxamide, dihydrochloride

試薬・触媒・溶媒 3

HCID 6212Chloroform溶媒HCID 6344Dichloromethane溶媒HCID 516892Sodium Bicarbonate溶媒

実験手順

Carbonyidiimidazole (0.045 g, 0.137 mmol), was added to a solution of Example 26 (0.050 g, 0.125 mmol), and triethylamine (0.038 mL, 0.275 mmol) in dry methylene chloride (1 mL) at rt under argon. After stirring for 2 hr, piperidine (0.013 mL, 0.13 mmol) was added. After stirring for 15 hr, the reaction was diluted with NaHCO3 and CHCl3. The organic layer was washed with NaHCO3, water, and brine (1×3 mL each), dried over MgSO4, filtered and concentrated. The product was purified by reverse phase HPLC with a gradient of 40-90% aquous methanol with 0.1% TFA and the HCl salt was formed by treatment with 1M HCl/ether to afford Example 247 (0.006 g, 10%).

後処理

  1. stirringAfter stirring for 15 hr
  2. washThe organic layer was washed with NaHCO3, water, and brine (1×3 mL each)
  3. dry with materialdried over MgSO4
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customThe product was purified by reverse phase HPLC with a gradient of 40-90% aquous methanol with 0.1% TFA

出典と根拠

ORDレコード
ord-2139a2414ebb49b38fba161beabdfbc8
出典データセット
uspto-grants-2000_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06011029

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート